On September 2nd, 2020 Cathelijne van der Wouden obtained her PhD degree from Leiden University in the Netherlands. She started her PhD in 2016 in the research group of Prof. Henk-Jan Guchelaar and Dr. Jesse Swen from the Leiden University Medical Center.
She had a huge roll in designing and managing the PREPARE trial. Her work resulted in the thesis entitled ‘Precision medicine using pharmacogenomic panel testing’.
Dr. van der Wouden continues her career as an Associate Consultant for Life Sciences at McKinsey and Company in Zürich, Switzerland.
